Bank Of America Corp Lyell Immunopharma, Inc. Transaction History
Bank Of America Corp
- $1.06 Trillion
- Q1 2024
A detailed history of Bank Of America Corp transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 219,481 shares of LYEL stock, worth $355,559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
219,481
Previous 1,660,589
86.78%
Holding current value
$355,559
Previous $3.22 Million
84.82%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding LYEL
# of Institutions
128Shares Held
144MCall Options Held
0Put Options Held
5.9K-
Mwg Management Ltd. Washington, DC20.2MShares$32.7 Million33.29% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$24.5 Million19.02% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$24.5 Million42.56% of portfolio
-
Black Rock Inc. New York, NY13.9MShares$22.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$21.7 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $401M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...